Enter your login e-mail to the account
Search
Search parameters
Search results
- Victoza (liraglutid)
MUDr. Jitka Jurková
(4/2011, Drugs & drug classes ) - The choice of antidiabetic medications with regard to metabolic syndrome
doc. MUDr. Alena Šmahelová, PhD.
(11/2009, Review articles ) - GLITAZONES – PAST, PRESENT AND FUTURE
PharmDr. Tomáš Tesař, PhD., MBA, MUDr. Adriana Ilavská
(9/2008, clearly ) - Metabolic surgery – surgery of obesity
MUDr. Pavol Holéczy, CSc.
(1/2016, Topic of the year ) - Diabetes and obesity (diabesity) and COVID-19
doc. MUDr. Ľubomíra Fábryová, PhD., MPH
(4/2022, Topic of the year ) - Antiatherogenic effect and cardiovascular benefit of GLP-1 receptor´s agonists
doc. MUDr. Štefan Farský, CSc., FESC
(4/2022, Drugs & drug classes ) - Efficiency and safety of linagliptin – relevance to clinical practice
doc. MUDr. Martin Prázný, CSc., Ph.D., MUDr. Jan Šoupal
(2/2014, Review articles ) - Správa zo XIV. slovenských obezitologických dní s medzinárodnou účasťou
MUC. Michal Pečík
(5/2016, Events ) - Relative safety of new obesity drugs: latest evidence and patient management
MUDr. Ľubomíra Fábryová, PhD.
(2/2017, Topic of the year ) - Metabolické ochorenia – čoraz väčšia výzva pre výskum i klinickú prax
MUDr. Fábryová Ľubomíra, PhD.
(5/2012, Editorial ) - Artériová hypertenzia: klinické a výskumné trendy 2015. XIII. sympózium o artériovej hypertenzii v Prahe (Česká republika)
doc. MUDr. Marian Sninčák, CSc., mim. prof.
(3/2015, Events ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - INCRETINS, INCRETIN EFFECT AND DIABETES MELLITUS
MUDr. Adriana Ilavská
(S4/2007, Supplement ) - Metabolic changes after bariatric surgery
MUDr. Pavol Holéczy, CSc., Mgr. Marek Bužga, PhD.
(2/2016, Topic of the year ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - New possibilities of treatment of type 2 diabetes mellitus
MUDr. Vladimír Uličiansky, doc. MUDr. Zbynek Schroner, PhD.
(3-4/2014, Review articles ) - GLP-1 receptor agonists in therapy of obesity
doc. MUDr. Zbynek Schroner, PhD.
(2/2022, Drugs & drug classes ) - News in pharmacological treatment of obesity/diabesity
doc. MUDr. Ľubomíra Fábryová, PhD., MPH
(5/2022, Topic of the year ) - Metformin – current position in the treatment of type 2 diabetes mellitus and discussed questions of its using
MUDr. Vladimír Uličiansky, doc. MUDr. Zbynek Schroner, PhD.
(4/2015, Review articles ) - Weight loss pharmacotherapy of obese non-diabetic and type 2 diabetic patients
MUDr. Ľubomíra Fábryová, PhD.
(6/2015, Topic of the year ) - Cardiovascular risk in diabetics
prof. MUDr. Miroslav Souček, CSc., MUDr. Petr Žák
(6/2015, Review articles ) - Sitagliptine – representative of the new group of drugs indicated in the treatment of type 2 diabetes mellitus
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(4/2010, Drugs & drug classes ) - INCRETIN-BASED THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(7-8/2008, Topic ) - WEIGHT MANAGEMENT FOR OBESE TYPE 2 DIABETICS
MUDr. Ľubomíra Fábryová, PhD.
(7-8/2008, Topic ) - Diabetes and heart failure
prof. MUDr. Ján Murín, CSc., doc. MUDr. Jozef Bulas, CSc.
(1/2014, Review articles ) - SPRÁVA Z XVIII. DIABETOLOGICKÝCH DNÍ 28. – 30. MÁJ 2008, KOŠICE
MUDr. Slávka Kalinová, PhD.
(7-8/2008, Events ) - Metabolic surgery in the treatment algorithm of obese type 2 diabetic patients
MUDr. Ľubomíra Fábryová, PhD.
(1/2017, Topic of the year ) - Diabesity, an increasing medical problem – diabetologist must be therefore also an obesitologist
doc. MUDr. Boris Krahulec, CSc., MUDr. Daša Mesárošová, PhD.
(4/2016, Topic of the year ) - Possibilities of prevention of type 2 diabetes mellitus in individuals with prediabetic dysglycemias
MUDr. Vladimír Uličiansky, doc. MUDr. Zbynek Schroner, PhD.
(4/2016, Review articles ) - MANAGEMENT OF OBESE PATIENTS WITH CARDIOMETABOLIC RISK
doc. MUDr. Boris Krahulec, CSc., MUDr. Dáša Mesárošová
(3/2008, Topic ) - The most significant news of the year 2023 in the pharmacology management of obesity
doc. MUDr. Ľubomíra Fábryová, PhD., MPH
(2/2024, Topic of the year )
- Diabetes mellitus: současný pohled na patogenezi, klasifikaci a léčbu
prof. MUDr. Michal Anděl, CSc.
(1/2007, From the boundary of neurology ) - Alzheimer’s disease and type 2 diabetes mellitus
doc. MUDr. Roman Jirák, CSc., doc. MUDr. Miroslav Zeman, CSc.
(2/2012, From the boundary of neurology )
- Influenza – vaccination is basis of prevention
prof. MUDr. Jiří Beran, CSc.
(6/2010, Review articles ) - CFRD – Cystic Fibrosis Related Diabetes
MUDr. Jaroslava Orosová, MUDr. Nina Bližnáková, MUDr. Ingrid Mikulášová, doc. MUDr. Vladimír Pohanka, PhD., MPH, FCCP
(6/2016, Review articles )
- Perorální antidiabetika – současnost
prof. MUDr. Jindřiška Perušičová, DrSc.
(1/2009, Drugs & drug classes ) - DIABETES MELLITUS TYPE 2 TREATMENT – ORAL ANTIDIABETIC AGENTS
MUDr. Pavlína Piťhová
(2/2007, clearly ) - MANAGEMENT OF OBESE PATIENTS WITH CARDIOMETABOLIC RISK
doc. MUDr. Boris Krahulec, CSc., MUDr. Dáša Mesárošová
(2/2008, Review articles )
- News in pharmacological treatment of obesity/diabesity
doc. MUDr. Ľubomíra Fábryová, PhD., MPH
(2/2023, Current pharmacotherapy ) - Nové liečivá v EÚ registrované v roku 2014 (II.)
Mgr. Zuzana Šestáková, PharrmDr. Peter Stanko
(2/2015, New drugs ) - The 42nd Days of Pharmacy with main topic „Diabetes“ – epidemic of the third millennium
doc. RNDr. Magdaléna Fulmeková, CSc.
(2/2016, Events ) - Victoza (liraglutid)
MUDr. Jitka Jurková
(3/2011, New medicinal substances ) - Sitagliptin
Ondřej Krystyník
(1/2011, New medicinal substances ) - Nové liečivá v EÚ registrované v roku 2013 (III.)
PharmDr. Peter Stanko
(2-3/2014, New drugs ) - Nové liečivá v EÚ registrované v roku 2013 (I.)
PharmDr. Peter Stanko
(4/2013, New drugs ) - Starostlivosť lekárnika o pacientov s diabetom
PharmDr. Marcel Jusko, PhD.
(2/2013, For pharmaceutical laboratory technicians )
- Periférne artériové ochorenie dolných končatín a globálne kardiovaskulárne riziko – možnosti ovplyvnenia v klinickej praxi
MUDr. Denisa Čelovská, PhD., prof. MUDr. Viera Štvrtinová, CSc., MUC. Mária Balgová
(1/2018, Main topic ) - XIX. SLOVENSKO-ČESKÁ KONFERENCIA O HEMOSTÁZE A TROMBÓZE S MEDZINÁRODNOU ÚČASŤOU
(S2/2012, Supplement )